Cargando…
Following the Fate of Dye-Containing Liposomes In Vitro
The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402323/ https://www.ncbi.nlm.nih.gov/pubmed/32659908 http://dx.doi.org/10.3390/ijms21144847 |
_version_ | 1783566734386528256 |
---|---|
author | Cauzzo, Jennifer Nystad, Mona Holsæter, Ann Mari Basnet, Purusotam Škalko-Basnet, Nataša |
author_facet | Cauzzo, Jennifer Nystad, Mona Holsæter, Ann Mari Basnet, Purusotam Škalko-Basnet, Nataša |
author_sort | Cauzzo, Jennifer |
collection | PubMed |
description | The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate through fluorescence-based assays, namely flow cytometry and imaging. These methods are often used to follow the nanocarrier internalization and targeting; however, the validity of the obtained results strictly depends on how much the nanosystem’s fate can be inferred from the fate of fluorescent dyes. To evaluate the parameters that affect the physicochemical and biological stability of the labeled nanosystems, we studied the versatility of two lipid dyes, TopFluor(®)-PC and Cy5-DSPE, in conventional liposomes utilizing well-defined in vitro assays. Our results suggest that the dye can affect the major characteristics of the system, such as vesicle size and zeta-potential. However, a nanocarrier can also affect the dye properties. Medium, temperature, time, fluorophore localization and its concentration, as well as their interplay, affect the outcome of tracing experiments. Therefore, an in-depth characterization of the labeled nanosystem should be fundamental to understand the conditions that validate the results within the screening process in optimization of nanocarrier. |
format | Online Article Text |
id | pubmed-7402323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74023232020-08-18 Following the Fate of Dye-Containing Liposomes In Vitro Cauzzo, Jennifer Nystad, Mona Holsæter, Ann Mari Basnet, Purusotam Škalko-Basnet, Nataša Int J Mol Sci Article The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate through fluorescence-based assays, namely flow cytometry and imaging. These methods are often used to follow the nanocarrier internalization and targeting; however, the validity of the obtained results strictly depends on how much the nanosystem’s fate can be inferred from the fate of fluorescent dyes. To evaluate the parameters that affect the physicochemical and biological stability of the labeled nanosystems, we studied the versatility of two lipid dyes, TopFluor(®)-PC and Cy5-DSPE, in conventional liposomes utilizing well-defined in vitro assays. Our results suggest that the dye can affect the major characteristics of the system, such as vesicle size and zeta-potential. However, a nanocarrier can also affect the dye properties. Medium, temperature, time, fluorophore localization and its concentration, as well as their interplay, affect the outcome of tracing experiments. Therefore, an in-depth characterization of the labeled nanosystem should be fundamental to understand the conditions that validate the results within the screening process in optimization of nanocarrier. MDPI 2020-07-09 /pmc/articles/PMC7402323/ /pubmed/32659908 http://dx.doi.org/10.3390/ijms21144847 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cauzzo, Jennifer Nystad, Mona Holsæter, Ann Mari Basnet, Purusotam Škalko-Basnet, Nataša Following the Fate of Dye-Containing Liposomes In Vitro |
title | Following the Fate of Dye-Containing Liposomes In Vitro |
title_full | Following the Fate of Dye-Containing Liposomes In Vitro |
title_fullStr | Following the Fate of Dye-Containing Liposomes In Vitro |
title_full_unstemmed | Following the Fate of Dye-Containing Liposomes In Vitro |
title_short | Following the Fate of Dye-Containing Liposomes In Vitro |
title_sort | following the fate of dye-containing liposomes in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402323/ https://www.ncbi.nlm.nih.gov/pubmed/32659908 http://dx.doi.org/10.3390/ijms21144847 |
work_keys_str_mv | AT cauzzojennifer followingthefateofdyecontainingliposomesinvitro AT nystadmona followingthefateofdyecontainingliposomesinvitro AT holsæterannmari followingthefateofdyecontainingliposomesinvitro AT basnetpurusotam followingthefateofdyecontainingliposomesinvitro AT skalkobasnetnatasa followingthefateofdyecontainingliposomesinvitro |